Nonsedating neurotransmitter-modulating supplement for nonvasomotor sleep disturbance in menopause.
OBJECTIVE To evaluate a GABAergic, melatonergic, and glutamatergic supplement for enhancing sleep quality in perimenopausal and postmenopausal women with low vasomotor symptom (VMS) burden. METHODS A randomized, double-blind, placebo-controlled, decentralized trial (NCT07375095) was performed in healthy perimenopausa...